Literature DB >> 16534203

Assessment of morphological and immunohistological alterations in long-term keloid skin explants.

Hai S Duong1, Qunzhou Zhang, Abraham Kobi, Anh Le, Diana V Messadi.   

Abstract

One of the major impediments in keloid research is the lack of a keloid animal model that can mimic human keloid. This imposes investigative constraints on studying cellular interactions and biochemical processes that normally occur in vivo. Our main objective is to establish an in vitro model for maintaining long-term viable keloid dermal explants as a tool for investigating the pathogenesis of keloid scar formation. Explants of adult keloid scars were cultured in vitro by embedding them in enriched collagen gel matrix and maintaining them for up to 6 weeks, whereupon changes in tissue morphology and cellular differentiation were examined. The effects of medium enrichment, air versus liquid submersion, and different substrates on the explants were examined. Our results indicated that keloid explants embedded in a collagen gel matrix were morphologically better preserved than explants placed on a plastic substrate. Explants with epidermis at the air-liquid interface had better morphology than collagen-submerged explants, and there were no differences between serum-free and serum-supplemented explant cultures. Immunohistochemical and apoptotic analyses were performed to assess cellular viability and differentiation. In situ hybridization confirmed that keloid fibroblasts had sustained collagen type I gene expression throughout the 6 weeks in culture, thus validating the integrity of a long-term keloid culture system. In conclusion, the collagen-embedded skin explant system demonstrates that keloid tissues could be maintained for up to 6 weeks for long-term in vitro studies. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16534203     DOI: 10.1159/000091098

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  6 in total

1.  In vitro study of novel collagenase (XIAFLEX®) on Dupuytren's disease fibroblasts displays unique drug related properties.

Authors:  Farhatullah Syed; Alexis N Thomas; Subir Singh; Venkatesh Kolluru; Susan G Emeigh Hart; Ardeshir Bayat
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

Review 2.  Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective.

Authors:  Lenie J van den Broek; Grace C Limandjaja; Frank B Niessen; Susan Gibbs
Journal:  Exp Dermatol       Date:  2014-06       Impact factor: 3.960

3.  Functional testing of topical skin formulations using an optimised ex vivo skin organ culture model.

Authors:  G P Sidgwick; D McGeorge; A Bayat
Journal:  Arch Dermatol Res       Date:  2016-04-16       Impact factor: 3.017

Review 4.  The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models.

Authors:  Grace C Limandjaja; Frank B Niessen; Rik J Scheper; Susan Gibbs
Journal:  Front Cell Dev Biol       Date:  2020-05-26

5.  Long-term explant culture: an improved method for consistently harvesting homogeneous populations of keloid fibroblasts.

Authors:  Jing Li; Yuqing Zou; Song Wang; Shikai Guo; Zhishun Huang; Ran Huo
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

6.  Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.

Authors:  Wenbo Wang; Miao Qu; Lan Xu; Xiaoli Wu; Zhen Gao; Tingyu Gu; Wenjie Zhang; Xiaoyan Ding; Wei Liu; Yue-Lei Chen
Journal:  J Mol Med (Berl)       Date:  2016-06-24       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.